Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Diabetes, obesity & metabolism"
topic_facet:"Benzhydryl Compounds"
topic_facet:"SGLT2 inhibitor"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%22Benzhydryl+Compounds%22&filter%5B%5D=topic_facet%3A%22SGLT2+inhibitor%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%22Benzhydryl+Compounds%22&filter%5B%5D=topic_facet%3A%22SGLT2+inhibitor%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%22Benzhydryl+Compounds%22&filter%5B%5D=topic_facet%3A%22SGLT2+inhibitor%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
PubPharm (12)
1
Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes : A post hoc analysis of pooled data from four phase 3 randomized clinical trials
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Lund, S.
|
Sattar, N.
|
Salsali, A.
| +2
Wird geladen...
2
Sustained 52-week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes
enthalten in:
Diabetes, obesity & metabolism
| 2019
von
Handelsman, Y.
|
Mathieu, C.
|
Del Prato, S.
| +5
Wird geladen...
3
Empagliflozin compared with glimepiride in metformin-treated patients with type 2 diabetes : 208-week data from a masked randomized controlled trial
enthalten in:
Diabetes, obesity & metabolism
| 2018
von
Ridderstråle, M.
|
Rosenstock, J.
|
Andersen, K.
| +3
Wird geladen...
4
Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION-8 study
enthalten in:
Diabetes, obesity & metabolism
| 2018
von
Jabbour, S.
|
Frías, J.
|
Guja, C.
| +3
Wird geladen...
5
Efficacy and safety of triple therapy with dapagliflozin add-on to saxagliptin plus metformin over 52 weeks in patients with type 2 diabetes
enthalten in:
Diabetes, obesity & metabolism
| 2016
von
Mathieu, C.
|
Herrera Marmolejo, M.
|
González González, J.
| +5
Wird geladen...
6
Efficacy and safety of empagliflozin in patients with type 2 diabetes from Asian countries : pooled data from four phase III trials
enthalten in:
Diabetes, obesity & metabolism
| 2016
von
Yoon, K.
|
Nishimura, R.
|
Lee, J.
| +4
Wird geladen...
7
Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
enthalten in:
Diabetes, obesity & metabolism
| 2015
von
Chilton, R.
|
Tikkanen, I.
|
Cannon, C.
| +4
Wird geladen...
8
Durability and tolerability of dapagliflozin over 52 weeks as add-on to metformin and sulphonylurea in type 2 diabetes
enthalten in:
Diabetes, obesity & metabolism
| 2015
von
Matthaei, S.
|
Bowering, K.
|
Rohwedder, K.
| +4
Wird geladen...
9
Long-term treatment with empagliflozin as add-on to oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus
enthalten in:
Diabetes, obesity & metabolism
| 2015
von
Araki, E.
|
Tanizawa, Y.
|
Tanaka, Y.
| +6
Wird geladen...
10
Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes : 4-year data
enthalten in:
Diabetes, obesity & metabolism
| 2015
von
Del Prato, S.
|
Nauck, M.
|
Durán-Garcia, S.
| +4
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: Diabetes, obesity & metabolism
Filter aufheben
Thema: Benzhydryl Compounds
Filter aufheben
Thema: SGLT2 inhibitor
Medienart
12
Aufsätze
12
E-Artikel
12
E-Ressourcen
Zeitschriftentitel
Diabetes, obesity & metabolism
Thema
Benzhydryl Compounds
12
Clinical Trial, Phase III
12
Glucosides
12
Journal Article
12
Randomized Controlled Trial
SGLT2 inhibitor
11
Hypoglycemic Agents
10
Research Support, Non-U.S. Gov't
9
9100L32L2N
9
Glycated Hemoglobin A
9
Metformin
8
Blood Glucose
8
Multicenter Study
8
type 2 diabetes
7
1ULL0QJ8UC
7
dapagliflozin
7
hemoglobin A1c protein, human
5
HDC1R2M35U
5
empagliflozin
4
phase III study
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2020-
11
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
12
Englisch
Haven't found what you're looking for?
Wird geladen...